
Resources
-
Managing Accelerated Development Industry Experience
Speaker Presentation Momonoi Yoko Celgene 2019
-
Comparability Approach for an Individualized Product
Speaker Presentation Kuhn Andreas Genentech 2019
-
FDA Perspective on Commercial Facility Design for Cell and Gene Therapy Products
Speaker Presentation Koo Lily US FDA 2019
-
FDA’s Regulatory Perspective on Individualized Neoantigen‐specific Cancer Vaccines
Speaker Presentation Husain Syed US FDA 2019
-
Regulation of Regenerative Medicine in Taiwan
Speaker Presentation Hung Wen Yi Taiwan FDA 2019
-
Recent Developments in ATMP Regulation in Europe
Speaker Presentation Hoefnagel Marcel Medicines Evaluation Board 2019
-
Regulatory Updates for Human Cell Therapy Products: An FDA Perspective
Speaker Presentation Eacho Melanie US FDA 2019
-
Breaking the Traditional CMC Development Pathway
Speaker Presentation Beumer Sassi Alex Voisin Consulting 2019
-
Address the Need of Standards Development in the CGT Space: SCB & Standards Initiatives
Speaker Presentation Zhang Jiwen Tmunity Therapeutics 2018
-
Process Considerations for Cryogenic Shipping
Speaker Presentation Vermeyen Craig Kite Pharma 2018
-
Genetically Modified Cells: Regulatory Expectations for Marketing Authorization in Europe
Speaker Presentation Timon Marcos AEMPS 2018
-
Lifecycle Management: Challenges and Lessons Learned from Kymriah™ (CD19 CAR T)
Speaker Presentation Thatcher Anthony Novartis 2018
-
Comparability Studies - Unique Challenges and Key Considerations for Cell and Gene Therapy Products (CGTPs)
Speaker Presentation Taraporewala Zenobi CBER FDA 2018
-
Regulatory Update for Cell and Gene Therapies -Health Canada
Speaker Presentation Storbeck Christophe Health Canada 2018
-
Manufacturing of Gene Therapy Products: Advances in Process Development and Scale-Up Methods to Meet Future Demand
Speaker Presentation Simpson Curran REGENXBIO 2018
-
Clinical Trials with ATMPs in Europe Getting Started
Speaker Presentation Reischl Ilona BASG/AGES 2018
-
Standards for Cell Therapy, Case Study: CD34+ Cell Enumeration Standards
Speaker Presentation Potts Rebecca USP 2018
-
Lentiviral Vectors – Considerations for Their Use in Gene-Modified Cell Therapy Production
Speaker Presentation Miskin James Oxford BioMedica 2018
-
Comparability Is Not a Nightmare, Just Think Ahead
Speaker Presentation Menezes Ferreira Margarida Infarmed 2018
-
Considerations in Validating Car T Cell Therapy Manufacturing Processes
Speaker Presentation Mccue Justin Juno 2018